Glioblastoma brain cancer cells that are more resistant to radiation therapy have higher levels of purines. Reducing the level of purines made the cancer cells more sensitive to radiation. Read More
Trifluoperazine, a dopamine receptor antagonist commonly prescribed for schizophrenia, used in combination with radiation therapy delays the growth of glioblastoma brain tumors and prolongs survival for brain cancer. Read More
Researchers report improved survival rates in people who received chemotherapy postoperatively for medulloblastoma brain cancer. Read More
Researchers discover reduced gray matter volume and enlarged ventricular spaces in the brains of glioblastoma patients who have undergone chemoradiation therapies. The brain changes appear early and are progressive. Read More
